# Air T Inc: financial statements, quarterly

AIRT · Nasdaq · CIK 353184 · [Industrials](/sectors/industrials.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/airt.md) · [Financials](/companies/airt/financials.md) · [Filings](/companies/airt/filings.md) · [Insiders](/companies/airt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/airt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [79.0](/filings/0000353184-24-000133.md) | [63.8](/filings/0000353184-25-000009.md) | [72.7 d](/filings/0000353184-25-000069.md) | [66.4](/filings/0000353184-25-000073.md) | [81.2](/filings/0000353184-25-000126.md) | [77.9](/filings/0000353184-26-000016.md) | [66.3 d](/filings/0000353184-26-000054.md) | [70.9](/filings/0000353184-26-000077.md) | [64.2](/filings/0000353184-25-000126.md) | [71.1](/filings/0000353184-26-000016.md) | [121 d](/filings/0000353184-26-000054.md) | [115](/filings/0000353184-26-000077.md) |
| Research and development | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [0.8](/filings/0000353184-24-000133.md) | [(1.6)](/filings/0000353184-25-000009.md) | [1.5 d](/filings/0000353184-25-000069.md) | [(0.6)](/filings/0000353184-25-000073.md) | [3.6](/filings/0000353184-25-000126.md) | [1.4](/filings/0000353184-26-000016.md) | [(2.6) d](/filings/0000353184-26-000054.md) | [0.8](/filings/0000353184-26-000077.md) | [5.5](/filings/0000353184-25-000126.md) | [(3.8)](/filings/0000353184-26-000016.md) | [(13.8) d](/filings/0000353184-26-000054.md) | [(12.8)](/filings/0000353184-26-000077.md) |
| Interest expense | $m | [1.9](/filings/0000353184-23-000144.md) | [1.5](/filings/0000353184-24-000010.md) | [1.7 d](/filings/0000353184-25-000069.md) | [1.9](/filings/0000353184-25-000073.md) | [2.2](/filings/0000353184-25-000126.md) | [2.6](/filings/0000353184-26-000016.md) | [1.7 d](/filings/0000353184-26-000054.md) | [2.3](/filings/0000353184-26-000077.md) | [2.3](/filings/0000353184-25-000126.md) | [2.4](/filings/0000353184-26-000016.md) | [5.1 d](/filings/0000353184-26-000054.md) | [5.7](/filings/0000353184-26-000077.md) |
| Income tax | $m | [0.5](/filings/0000353184-24-000133.md) | [0.2](/filings/0000353184-25-000009.md) | [(0.1) d](/filings/0000353184-26-000054.md) | [0.1](/filings/0000353184-25-000073.md) | [0.3](/filings/0000353184-25-000126.md) | [0.3](/filings/0000353184-26-000016.md) | [(0.3) d](/filings/0000353184-26-000054.md) | [(0.1)](/filings/0000353184-26-000077.md) | [2.2](/filings/0000353184-25-000126.md) | [0.1](/filings/0000353184-26-000016.md) | [(0.8) d](/filings/0000353184-26-000054.md) | [0.7](/filings/0000353184-26-000077.md) |
| Net income | $m | [(1.6)](/filings/0000353184-24-000133.md) | [(3.0)](/filings/0000353184-25-000009.md) | [(1.7) d](/filings/0000353184-25-000069.md) | [(0.3)](/filings/0000353184-25-000073.md) | [2.5](/filings/0000353184-25-000126.md) | [(1.3)](/filings/0000353184-26-000016.md) | [(7.0) d](/filings/0000353184-26-000054.md) | [(1.6)](/filings/0000353184-26-000077.md) | [4.4](/filings/0000353184-25-000126.md) | [(2.5)](/filings/0000353184-26-000016.md) | [77.7 d](/filings/0000353184-26-000054.md) | [(15.8)](/filings/0000353184-26-000077.md) |
| Diluted EPS | $ per share | [(0.57)](/filings/0000353184-24-000133.md) | [(1.06)](/filings/0000353184-25-000009.md) | not reported | [(0.12)](/filings/0000353184-25-000073.md) | [0.91](/filings/0000353184-25-000126.md) | [(0.47)](/filings/0000353184-26-000016.md) | not reported | [(0.61)](/filings/0000353184-26-000077.md) | [1.61](/filings/0000353184-25-000126.md) | [(0.91)](/filings/0000353184-26-000016.md) | not reported | [(5.86)](/filings/0000353184-26-000077.md) |
| Basic EPS | $ per share | [(0.57)](/filings/0000353184-24-000133.md) | [(1.06)](/filings/0000353184-25-000009.md) | not reported | [(0.12)](/filings/0000353184-25-000073.md) | [0.91](/filings/0000353184-25-000126.md) | [(0.47)](/filings/0000353184-26-000016.md) | not reported | [(0.61)](/filings/0000353184-26-000077.md) | [1.61](/filings/0000353184-25-000126.md) | [(0.91)](/filings/0000353184-26-000016.md) | not reported | [(5.86)](/filings/0000353184-26-000077.md) |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Research and development: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | FY2026 (2026-03-31) | Q1 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [5.0](/filings/0000353184-23-000144.md) | [4.5](/filings/0000353184-24-000010.md) | [7.1](/filings/0000353184-25-000069.md) | [7.8](/filings/0000353184-24-000097.md) | [8.6](/filings/0000353184-24-000133.md) | [18.5](/filings/0000353184-25-000009.md) | [5.9](/filings/0000353184-26-000054.md) | [14.5](/filings/0000353184-25-000073.md) | [17.5](/filings/0000353184-25-000126.md) | [37.4](/filings/0000353184-26-000016.md) | [20.3](/filings/0000353184-26-000077.md) | [16.7](/filings/0000353184-26-000077.md) |
| Current assets | $m | [98.3](/filings/0000353184-23-000144.md) | [89.3](/filings/0000353184-24-000010.md) | [103](/filings/0000353184-25-000069.md) | [101](/filings/0000353184-24-000097.md) | [103](/filings/0000353184-24-000133.md) | [90.1](/filings/0000353184-25-000009.md) | [78.5](/filings/0000353184-26-000054.md) | [92.9](/filings/0000353184-25-000073.md) | [95.8](/filings/0000353184-25-000126.md) | [161](/filings/0000353184-26-000016.md) | [160](/filings/0000353184-26-000077.md) | [158](/filings/0000353184-26-000077.md) |
| Total assets | $m | [172](/filings/0000353184-23-000144.md) | [163](/filings/0000353184-24-000010.md) | [177](/filings/0000353184-25-000069.md) | [175](/filings/0000353184-24-000097.md) | [197](/filings/0000353184-24-000133.md) | [188](/filings/0000353184-25-000009.md) | [174](/filings/0000353184-26-000054.md) | [190](/filings/0000353184-25-000073.md) | [185](/filings/0000353184-25-000126.md) | [382](/filings/0000353184-26-000016.md) | [409](/filings/0000353184-26-000077.md) | [469](/filings/0000353184-26-000077.md) |
| Current liabilities | $m | [50.8](/filings/0000353184-23-000144.md) | [44.8](/filings/0000353184-24-000010.md) | [46.8](/filings/0000353184-25-000069.md) | [46.9](/filings/0000353184-24-000097.md) | [45.1](/filings/0000353184-24-000133.md) | [47.3](/filings/0000353184-25-000009.md) | [47.7](/filings/0000353184-26-000054.md) | [49.1](/filings/0000353184-25-000073.md) | [46.4](/filings/0000353184-25-000126.md) | [168](/filings/0000353184-26-000016.md) | [95.5](/filings/0000353184-26-000077.md) | [111](/filings/0000353184-26-000077.md) |
| Total liabilities | $m | [149](/filings/0000353184-23-000144.md) | [142](/filings/0000353184-24-000010.md) | [158](/filings/0000353184-25-000069.md) | [163](/filings/0000353184-24-000097.md) | [181](/filings/0000353184-24-000133.md) | [174](/filings/0000353184-25-000009.md) | [168](/filings/0000353184-26-000054.md) | [185](/filings/0000353184-25-000073.md) | [177](/filings/0000353184-25-000126.md) | [376](/filings/0000353184-26-000016.md) | [318](/filings/0000353184-26-000077.md) | [386](/filings/0000353184-26-000077.md) |
| Long-term debt | $m | [108](/filings/0000353184-23-000144.md) | [101](/filings/0000353184-24-000010.md) | [113](/filings/0000353184-25-000069.md) | [112](/filings/0000353184-24-000097.md) | [127](/filings/0000353184-24-000133.md) | [123](/filings/0000353184-25-000009.md) | [110](/filings/0000353184-26-000054.md) | [124](/filings/0000353184-25-000073.md) | [118](/filings/0000353184-25-000126.md) | [194](/filings/0000353184-26-000016.md) | [208](/filings/0000353184-26-000077.md) | [246](/filings/0000353184-26-000077.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [9.9](/filings/0000353184-23-000144.md) | [6.9](/filings/0000353184-24-000010.md) | [4.8](/filings/0000353184-25-000069.md) | [4.1](/filings/0000353184-24-000097.md) | [7.0](/filings/0000353184-24-000133.md) | [5.1](/filings/0000353184-25-000009.md) | [(3.2)](/filings/0000353184-26-000054.md) | [(4.6)](/filings/0000353184-25-000073.md) | [0.1](/filings/0000353184-25-000126.md) | [(1.2)](/filings/0000353184-26-000016.md) | [79.8](/filings/0000353184-26-000077.md) | [65.2](/filings/0000353184-26-000077.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [12.4 d](/filings/0000353184-24-000133.md) | [7.2 d](/filings/0000353184-25-000009.md) | [(6.0) d](/filings/0000353184-25-000069.md) | [0.1](/filings/0000353184-25-000073.md) | [2.9 d](/filings/0000353184-25-000126.md) | [16.3 d](/filings/0000353184-26-000016.md) | [4.1 d](/filings/0000353184-26-000054.md) | [(1.1)](/filings/0000353184-26-000077.md) | [(5.4) d](/filings/0000353184-25-000126.md) | [(18.5) d](/filings/0000353184-26-000016.md) | [(0.0) d](/filings/0000353184-26-000054.md) | [(2.8)](/filings/0000353184-26-000077.md) |
| Capital expenditure | $m | [0.2 d](/filings/0000353184-24-000133.md) | [0.1 d](/filings/0000353184-25-000009.md) | [0.4 d](/filings/0000353184-25-000069.md) | [0.3](/filings/0000353184-25-000073.md) | [0.2 d](/filings/0000353184-25-000126.md) | [0.4 d](/filings/0000353184-26-000016.md) | [0.1 d](/filings/0000353184-26-000054.md) | [0.2](/filings/0000353184-26-000077.md) | [0.2 d](/filings/0000353184-25-000126.md) | [0.8 d](/filings/0000353184-26-000016.md) | [15.3 d](/filings/0000353184-26-000054.md) | [21.3](/filings/0000353184-26-000077.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: not reported

## Shares

| Line item | Unit | Q2 FY2023 (2022-09-30) | Q3 FY2023 (2022-12-31) | Q1 FY2024 (2023-06-30) | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q1 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [2,865](/filings/0000353184-23-000144.md) | [2,836](/filings/0000353184-24-000010.md) | [2,818](/filings/0000353184-24-000097.md) | [2,820](/filings/0000353184-24-000133.md) | [2,822](/filings/0000353184-25-000009.md) | [2,761](/filings/0000353184-25-000073.md) | [2,760](/filings/0000353184-25-000126.md) | [2,756](/filings/0000353184-26-000016.md) | [2,703](/filings/0000353184-26-000077.md) | [2,703](/filings/0000353184-25-000126.md) | [2,703](/filings/0000353184-26-000016.md) | [2,696](/filings/0000353184-26-000077.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 2,681,748 at 2026-07-31, from the cover of the [10-Q filed 2026-08-14](/filings/0000353184-26-000077.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.